XML 36 R26.htm IDEA: XBRL DOCUMENT v3.25.3
WARRANTS TO PURCHASE COMMON STOCK
 9 Months Ended
Sep. 30, 2025
Warrants To Purchase Common Stock  
WARRANTS TO PURCHASE COMMON STOCK

NOTE 15 – WARRANTS TO PURCHASE COMMON STOCK

 

The following table summarizes information with respect to outstanding warrants to purchase common stock of the Company at September 30, 2025:

 

Exercise   Number   Expiration 
Price   Outstanding   Date 
$1,056.00    4,585   April 2029 
$1,056.00    2,782   April 2029 
$1,056.00    2,172   April 2029 
$1,056.00    10,884   April 2029 
$1,600.00    36   October 2028 
$2,720.00    5,758   December 2028 
$3,200.00    22   August 2028 
      26,239     

 

During the nine months ended September 30, 2025, 13,666; 5,758 (as the Company received FDA acceptance of our NDA filing), and 1 warrants with an exercise price of $1,056, $1,776 and $364,800, respectively, expired.

 

During the nine months ended September 30, 2024, 113,155 prefunded common warrants were exercised.